Antitubercular agent

This page covers all Antitubercular agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting InhA (enoyl-acyl carrier protein reductase), RNA polymerase, InhA.

Targets

InhA (enoyl-acyl carrier protein reductase), RNA polymerase · InhA

Phase 3 pipeline (2)

• isoniazid and rifapentine · National Taiwan University Hospital · Infectious disease
  Isoniazid and rifapentine work by inhibiting the synthesis of mycolic acid in Mycobacterium tuberculosis, ultimately leading to the death of the bacteria.
• isoniazid , randomized, open label · National Taiwan University Hospital · Infectious disease
  Isoniazid inhibits the synthesis of mycolic acid in Mycobacterium tuberculosis by inhibiting the enzyme enoyl-acyl carrier protein reductase (InhA).